STOCKS TELEGRAPH

Tag: CRBP stock

  • Rally Continues For Corbus (CRBP) Stock After-Hours

    Rally Continues For Corbus (CRBP) Stock After-Hours

    A persistent upswing was observed on Tuesday in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP). Corbus stock continued the rally into the after-hours trading session, when the company’s stock increased by 13.28% to $28.50. This came after a notable rise of 35.12% during the regular trading session, which ended at $25.16. One explanation for the increased momentum was the execution of a strategic equity plan.

    In a recent announcement, Corbus (CRBP) stated that it intends to carry out an underwritten RPO, in which it would sell shares of its ordinary stock or, if preferred, pre-funded warrants to specific investors for the acquisition of shares. For all securities included in this offering, Corbus will be the sole vendor.

    The completion of the offering, as well as its size and terms, is contingent upon market conditions, with no guaranteed assurance of its occurrence or specific parameters. The net proceeds from this offering are earmarked for funding the clinical development of its pipeline, alongside utilization for working capital and other corporate purposes.

    Furthermore, during a significant event, data from the first-in-human clinical study of CRB-701 was presented as a poster by CRBP’s development partner, CSPC Pharmaceutical Group, at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU).

    CRB-701, equipped with innovative antibody and next-generation linker technology, demonstrates a distinctive pharmacokinetic profile compared to enfortumab vedotin (EV), showcasing a current safety profile without peripheral neuropathy and skin rash—known dose-limiting toxicities for EV.

    This distinction holds promise for metastatic urothelial carcinoma (mUC) patients and other solid tumors expressing nectin-4, such as cervical cancer. Upon evaluation of CRB-701’s emerging profile with an eminent expert in genitourinary cancers, the positive clinical responses observed in nectin-4 positive mUC and cervical cancer patients are encouraging.

    Additionally, the early clinical safety data presents the initial evidence of CRB-701’s clinical activity across various nectin-4 expressing tumors, warranting further investigation into the compound’s safety and efficacy. As the ongoing clinical study advances in China with partner CSPC, Corbus is strategically planning to initiate a clinical study in the United States in Q1 2024 under an already open Investigational New Drug (IND) application.

  • Corbus Pharmaceuticals Holdings Inc. (CRBP) Bounces Back on Data Presentation at AACR Annual Meeting

    On April 8, 2022, Corbus Pharmaceuticals Holdings Inc. (CRBP) announced the presentation of its CRB-601 preclinical data at the AACR Annual Meeting. Consequently, the stock bounced back in the after-hours to add 11.19%. Thus, CRBP reached a value of $0.4450 per share in the after-hours session on Friday. This rebound followed a downtrend of 5.26% in the prior trading session marking the closing price of $0.4002 per share.

    Source: Elseveir

    CRBP’s Data Presentation

    The company is currently presenting CRB-601’s preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2022. The meeting commenced on April 8 and will continue till April 13, 2022, in New Orleans, LA.

    The company is developing CRB-601 as a potential treatment for solid tumor cancers with IND submission expected in H1 2023. The in vitro preclinical data shows significant inhibition of tumor growth of colon cancer in a syngenetic model. Moreover, CRB-601 demonstrated positive inhibition both as a single agent as well as in combination with anti-PD-1 treatment. CRB-601 thus stimulates the increase of tumor infiltration by T-cells. Hence, with the positive data, CRBP is now looking forward to bringing the mechanism of action to the clinic.

    Immunology Market & its Return

    The Covid-19 pandemic had a huge impact on the global immunology market. As all resources and interest shifted towards possible cure and prevention development of the SARS-CoV-2 virus, the rest of the market shrank as demand declined. The global market grew just by 4.2% in 2020 but is now returning to pre-pandemic levels. Hence, the global immunology market is now expected to reach $158.69 billion by 2028 at a CAGR of 8.1%.

    While the pandemic impacted the market negatively, it did help increase awareness regarding immunological diseases. Furthermore, the rise in autoimmune diseases due to toxic environmental chemicals, stress, dietary components, and infections are propelling the market forward.

    CRBP’s Developments & Outlook

    Focusing on the nexus between the immune system and cancer, CRBP is working on developing a diversified pipeline. With its integrin program on schedule, the company plans to enter the clinical stage in 2023.

    Additionally, the company entered 2022 with cash and investments of $98.3 million which it finds enough to fund operations into Q1 2024.

    Conclusion

    With the return of the wider market to its pre-pandemic levels and its own progress on schedule, CRBP is looking towards entering the clinic in 2023.

    Currently, the company’s stock is enjoying gains on its latest presentation of positive data at the AACR Annual Meeting.

  • 49 Stocks Making Sharp Moves in Pre Market Session

    49 Stocks Making Sharp Moves in Pre Market Session

    BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc. (AWS). The most recent rating by TD Securities, on April 01, 2020, is a Hold.
    Gores Metropoulos Inc. (GMHI), a Shell Companies company, dropped about -3.71% at $16.37 in pre-market trading Wednesday.
    Carnival Corporation & Plc (NYSE: CCL) shares are trading up 2.48% at $20.65 at the time of writing. The firm recently reported Peter C. Anderson as a Section 16 Named Executive Officer. Company’s 52-week ranged between $7.80 to $51.94. Analysts have a consensus price target of $31.
    Guardion Health Sciences Inc. (GHSI) is up more than 2.11% at $0.3 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 11.71% to $0.29 in the last trading session.
    Advaxis Inc. (ADXS) grew over 0.85% at $0.32 in pre-market trading today. The healthcare company recently announced closing of $9.2 million public offering.
    Before the trading started on December 02, 2020, RiceBran Technologies (RIBT) is down -5.56% to reach $0.68. It has been trading in a 52-week range of $0.37 to $2.43.
    Sundial Growers Inc. (SNDL) stock moved up 5.75 percent to $0.69 in the pre-market trading and the company recently announced elimination of senior secured second lien convertible notes.
    Kaixin Auto Holdings (KXIN) is up more than 4.55% at $7.35 in pre-market hours Wednesday December 02, 2020. The stock had jumped over 8.32% to $7.03 in the last trading session.
    Moleculin Biotech Inc. (MBRX) lost over -7.83% at $0.9125 in pre-market trading Wednesday December 02, 2020 after declaring that the US Food and Drug Administration (FDA) has approved its request for a “Rare Pediatric Disease” designation for its drug candidate WP1066.
    Jaguar Health Inc. (JAGX) stock plunged -5.83% to $0.4313 in the pre-market trading. The most recent rating by Rodman & Renshaw, on July 11, 2017, is a Buy.
    Auris Medical Holding Ltd. (EARS) stock plunged -17.97% to $4.29 in the pre-market trading after reporting positive efficacy data from testing AM-301 in vitro. The most recent rating by Euro Pacific Capital, on October 08, 2018, is a Buy.
    Before the trading started on December 02, 2020, Sunworks Inc. (SUNW) is up 9.88% to reach $4.67. It has been trading in a 52-week range of $0.29 to $8.50.
    China Automotive Systems Inc. (NASDAQ: CAAS) shares are trading down -4.95% at $8.25 at the time of writing after the firm declared that its shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020. Company’s 52-week ranged between $1.42 to $10.50.
    Tilray Inc. (NASDAQ: TLRY) shares are trading up 1.61% at $8.2 at the time of writing. Company’s 52-week ranged between $2.43 to $22.95. Analysts have a consensus price target of $4.77.
    Ocugen Inc. (OCGN) lost over -8.87% at $0.3101 in pre-market trading Wednesday December 02, 2020. The company recently reported that leading independent proxy firms ISS and Glass Lewis recommended Ocugen stockholders vote “FOR” reverse stock split and authorized shares amendment proposals.
    AMC Entertainment Holdings Inc. (AMC) is up more than 2.41% at $4.25 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -2.81% to $4.15 in the last trading session.
    Before the trading started on December 02, 2020, JetBlue Airways Corporation (JBLU) is down -4.67% to reach $14.7 following the declaration of its pricing of common stock offering. It has been trading in a 52-week range of $6.61 to $21.65.
    Before the trading started on December 02, 2020, Uxin Limited (UXIN) is down -3.65% to reach $1.32. It has been trading in a 52-week range of $0.72 to $3.10.
    Li Auto Inc. (NASDAQ: LI) shares are trading up 1.78% at $35.48 at the time of writing after announcing that the Company delivered 4,646 Li ONEs in November 2020. Company’s 52-week ranged between $14.31 to $47.70. Analysts have a consensus price target of $45.60.
    Aurora Cannabis Inc. (ACB) stock soared 3.59% to $10.1 in the pre-market trading. The most recent rating by Jefferies, on November 16, 2020, is an Underperform.
    Tantech Holdings Ltd (TANH), a Household & Personal Products company, dropped about -3.24% at $1.79 in pre-market trading Wednesday after reporting the launch by its subsidiary, Shangchi Automobile Co., Ltd., of its newest highly innovative driverless and autonomous street sweeper.
    Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) shares are trading down -5.52% at $1.37 at the time of writing. Company’s 52-week ranged between $0.91 to $9.78. Analysts have a consensus price target of $3.
    iBio Inc. (IBIO) is up more than 19.31% at $1.73 in pre-market hours Wednesday December 02, 2020 after revealing that it has entered into its first Statement of Work (“SoW”) under a Master Services Agreement with ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. The stock had dropped over -2.68% to $1.45 in the last trading session.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 2.09% at $23.42 at the time of writing. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Moderna Inc. (MRNA) stock soared 6.09% to $149.6 in the pre-market trading. The biotechnology firm reported recently, that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The most recent rating by Wells Fargo, on November 23, 2020, is an Equal weight.
    Switchback Energy Acquisition Corporation (SBE) is down more than -4.16% at $28.13 in pre-market hours Wednesday December 02, 2020. The stock had dropped over -12.67% to $29.35 in the last trading session.
    Novavax Inc. (NVAX) grew over 4.84% at $129.44 in pre-market trading today after declaring COVID-19 vaccine clinical development progress.
    Before the trading started on December 02, 2020, Eastman Kodak Company (KODK) is up 3.88% to reach $7.5. It has been trading in a 52-week range of $1.50 to $60.00.
    ReneSola Ltd (SOL), a Solar company, dropped about -11.66% at $6.97 in pre-market trading Wednesday after releasing its third quarter 2020 financial results.
    Acasti Pharma Inc. (ACST) stock plunged -9.56% to $0.3301 in the pre-market trading. The most recent rating by Oppenheimer, on September 01, 2020, is a Perform.
    Pfizer Inc. (PFE) stock moved up 3.73 percent to $40.88 in the pre-market trading after the firm and BioNTech SE reporting that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19.
    Gevo Inc. (NASDAQ: GEVO) shares are trading down -3.17% at $1.83 at the time of writing. Company’s 52-week ranged between $0.46 to $2.91.
    Fisker Inc. (FSR) is down more than -3.41% at $17.55 in pre-market hours Wednesday December 02, 2020. The company recently reported that that Henrik Fisker, chairman and chief executive officer of Fisker, will participate in the Credit Suisse Eighth Annual Virtual Industrials Conference. The stock had dropped over -6.24% to $18.17 in the last trading session.
    Nxt-ID Inc. (NXTD) grew over 43.17% at $0.587 in pre-market trading today.
    Before the trading started on December 02, 2020, Bloom Energy Corporation (BE) is down -6.58% to reach $23.0 and the company will host virtual analyst day on December 16, 2020. It has been trading in a 52-week range of $3.00 to $28.24.
    Ocean Power Technologies Inc. (OPTT), a Electrical Equipment & Parts company, dropped about -3.54% at $2.45 in pre-market trading Wednesday.
    Nikola Corporation (NKLA) stock soared 4.38% to $18.13 in the pre-market trading after signing MOU with General Motors. The most recent rating by Loop Capital, on November 20, 2020, is a Buy.
    Vaxart Inc. (VXRT) gained over 3.92% at $7.95 in pre-market trading Wednesday December 02, 2020.
    salesforce.com inc. (CRM) lost over -4.16% at $231.3 in pre-market trading Wednesday December 02, 2020 after introducing service cloud workforce engagement to help contact centers thrive in an all-digital, work-from-anywhere world.
    InVivo Therapeutics Holdings Corp. (NVIV), a Biotechnology company, rose about 2.42% at $0.635 in pre-market trading Wednesday.
    FuelCell Energy Inc. (FCEL) stock plunged -20.11% to $7.23 in the pre-market trading following the publication pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
    Pershing Square Tontine Holdings Ltd. (PSTH), a Shell Companies company, rose about 2.34% at $26.25 in pre-market trading Wednesday.
    Virgin Galactic Holdings Inc. (NYSE: SPCE) shares are trading up 4.37% at $29.59 at the time of writing after reporting its new flight window since it paused the spaceflight preparations in response to state guidelines from the New Mexico Department of Health to reduce the spread of COVID-19. Company’s 52-week ranged between $7.14 to $42.49. Analysts have a consensus price target of $19.
    Second Sight Medical Products Inc. (EYES) stock moved down -8.0 percent to $1.38 in the pre-market trading.
    BioNTech SE (BNTX) grew over 7.36% at $122.4 in pre-market trading today after declaring that it will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2.
    Sogou Inc. (SOGO), a Internet Content & Information company, rose about 3.09% at $8.68 in pre-market trading Wednesday.
    Tellurian Inc. (TELL) is down more than -4.29% at $1.56 in pre-market hours Wednesday December 02, 2020 and the firm recently declared the appointment veteran CEO and adds industry experts to board of directors. The stock had jumped over 9.40% to $1.63 in the last trading session.
    Arlo Technologies Inc. (ARLO) lost over -3.48% at $6.66 in pre-market trading Wednesday December 02, 2020.
    Before the trading started on December 02, 2020, ZoomInfo Technologies Inc. (ZI) is down -3.57% to reach $46.22 as the firm announced pricing of secondary offering of shares of class a common stock. It has been trading in a 52-week range of $30.83 to $64.40.

  • What changed for these 50 stocks in Pre-Market Session?

    What changed for these 50 stocks in Pre-Market Session?

    Naked Brand Group Limited (NAKD) stock plunged -10.0% to $0.26 in the pre-market trading.

    Arcimoto Inc. (NASDAQ: FUV) shares are trading down -8.25% at $14.68 at the time of writing after Arcimoto and the city of Orlando launched a joint municipal pilot program to test ultra-efficient Electric Vehicles in city fleets. The company’s 52-week range was noted as $0.97 to $10.49. Analysts have a consensus price target of $8.

    HighPoint Resources Corporation (HPR) tumbled over -5.56% at $10.7 in pre-market trading today after Laredo Petroleum announced the appointment of Jarvis Hollingsworth and Lori Lancaster to the board of directors.

    Phoenix New Media Limited (FENG), an Internet Content & Information company, dropped about -4.29% at $2.23 in pre-market trading Friday after the company announced a special cash dividend of US$1.3712 per ADS.

    Ayro Inc. (AYRO) stock moved up 7.12 percent to $6.62 in the pre-market trading as the company revealed Q3 results.

    Titan Pharmaceuticals Inc. (TTNP) gained over 59.94% at $0.2735 in pre-market trading Friday 20 November 2020 following the announcement of its quarterly results.

    VAALCO Energy Inc. (EGY) is down more than -6.21% at $1.66 in pre-market hours Friday 20 November 2020 as the company announced that it has signed a sale and purchase agreement to acquire Sasol Gabon S.A.’s 27.8% working interest in the Etame Marin block offshore Gabon. The stock had jumped over 31.11% to $1.77 in the last trading session.

    Before the trading started on 20 November 2020, CIIG Merger Corp. (CIIC) is down -3.18% to reach $16.46. It has been trading in a 52-week range of $9.30 to $13.70.

    Kandi Technologies Group Inc. (KNDI) stock plunged -1.53% to $14.19 in the pre-market trading as the news surfaced that the company’s EV is entitled to a $2,500 Rebate in Texas.

    Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading down -28.33% at $4.2 at the time of writing after the company revealed it has entered into definitive agreements with investors for the sale of 25,000,000 of the Company’s American Depositary Shares at a price of $4.00 per ADS pursuant to a registered direct offering. The company’s 52-week range was noted as $0.51 to $6.00. Analysts have a consensus price target of $8.

    Medigus Ltd. (MDGS) tumbled over -0.81% at $2.45 in pre-market trading today. Correction after the news that the company aimed to form a joint venture with EMuze founders to develop and potentially commercialize EV-based micro-mobility vehicles for urban and logistics transportation.

    TransAtlantic Petroleum Ltd. (TAT), an Oil & Gas E&P company, rose about 13.65% at $0.2839 in pre-market trading Friday as the company revealed its Q3 results as offered a business update.

    Hudson Capital Inc. (HUSN) stock moved down -6.69 percent to $2.51 in the pre-market trading after the report of Hudson Capital Inc. and FreightHub, Inc. progressed further with the planned merger.

    Youdao Inc. (DAO) lost over -2.21% at $29.25 in pre-market trading Friday 20 November 2020 after the company reported third-quarter 2020 unaudited financial results.

    Jumia Technologies AG (JMIA) is down more than -2.6% at $23.6 in pre-market hours Friday 20 November 2020 after the reported that the company is finally narrowing losses after the pandemic forced a strategy shift. The stock had jumped over 18.37% to $24.23 in the last trading session.

    Before the trading started on 20 November 2020, CBAK Energy Technology Inc. (CBAT) is down -3.43% to reach $7.33. It has been trading in a 52-week range of $0.36 to $11.40.

    Polar Power Inc. (POLA) stock plunged -3.15% to $4.0 in the pre-market trading. The most recent rating by ROTH Capital, on November 07, 2017, is at a Neutral.

    Westwater Resources Inc. (NASDAQ: WWR) shares are trading up 5.48% at $6.16 at the time of writing after the company revealed Q3 results and offered a business update. The company’s 52-week range was noted as $0.25 to $14.50.

    Oragenics Inc. (OGEN) tumbled over -18.33% at $0.4296 in pre-market trading today after the Company announced that it has commenced a proposed underwritten public offering of common stock of the Company.

    Euroseas Ltd. (ESEA), a Marine Shipping company, dropped about -22.56% at $3.09 in pre-market trading Friday after the firm posted results for the nine-month period and the quarter ended September 30, 2020.

    Fuel Tech Inc. (FTEK) stock moved up 4.5 percent to $1.16 in the pre-market trading as the company revealed Q3 earnings report.

    SPI Energy Co. Ltd. (SPI) lost over -3.1% at $8.45 in pre-market trading Friday 20 November 2020 after the firm closed the sale of a 1.015-megawatt solar project in Maui, Hawaii.

    SG Blocks Inc. (SGBX) is down more than -12.28% at $2.5 in pre-market hours Friday 20 November 2020 after the publications reported that SG Blocks to deliver up to 7,000 COVID-19 PCR tests per shift leveraging Its state-of-the-Art D-TEC module lab solutions. The stock had jumped over 8.78% to $2.85 in the last trading session.

    Before the trading started on 20 November 2020, Senmiao Technology Limited (AIHS) is down 0.0% to reach $1.16, as the company revealed that it has recently launched Xixingtianxia, its own proprietary online ride-sharing platform, to drivers and riders in Chengdu, China, one of its core cities with a population of approximately 16 million. It has been trading in a 52-week range of $0.26 to $2.35.

    Teligent Inc. (TLGT) stock soared 11.65% to $0.6 in the pre-market trading after the company revealed adjournment of a special meeting of stockholders. The most recent rating by Craig Hallum, on August 20, 2020, is at a Hold.

    Waitr Holdings Inc. (NASDAQ: WTRH) shares are trading up 13.45% at $3.88 at the time of writing after the company revealed a Q3 earnings beat. The company’s 52-week range was noted as $0.26 to $5.85. Analysts have a consensus price target of $8.

    Ocean Power Technologies Inc. (OPTT) grew over 7.43% at $2.17 in pre-market trading today after the company revealed receipt of a DeepStar project award to study the deployment and operational requirements of utilizing OPT’s PB3 PowerBuoy to provide remotely controllable zero-carbon power for deepwater subsea oil production applications.

    Artelo Biosciences Inc. (ARTL), a Biotechnology company, rose about 42.51% at $0.8301 in pre-market trading Friday after the company announced receipt of the Clinical Trial Authorization in the UK for the Company’s Cancer Appetite Recovery Study.

    U.S. Energy Corp. (USEG) stock moved up 4.96 percent to $3.6 in the pre-market trading as the company revealed Q3 fiscal and operating results.

    Insignia Systems Inc. (ISIG) lost over -4.4% at $0.87 in pre-market trading Friday 20 November 2020 after the company revealed Q3 and nine months results.

    ADiTx Therapeutics Inc. (ADTX) is down more than -3.43% at $1.97 in pre-market hours Friday 20 November 2020. The stock had jumped over 5.70% to $2.04 in the last trading session. after company secures CLIA certification for AditxtScore Laboratory Operations in Richmond, VA, and plans to launch AditxtScore for COVID-19 as a lab-developed test.

    Before the trading started on 20 November 2020, FuelCell Energy Inc. (FCEL) is down -2.99% to reach $5.2 after the stock rally forced analysts to keep the stock status recommended. It has been trading in a 52-week range of $0.48 to $5.80.

    Lightbridge Corporation (LTBR) stock plunged -5.14% to $2.95 in the pre-market trading as the company revealed Q3 results.

    GSX Techedu Inc. (NYSE: GSX) shares are trading down -12.17% at $62.67 at the time of writing after the firm revealed its third-quarter 2020 results. The company’s 52-week range was noted as $14.21 to $141.78. Analysts have a consensus price target of $38.

    Reed’s Inc. (REED) tumbled over -21.09% at $0.5998 in pre-market trading today. Reed’s Inc after the company revealed outlook for fiscal 2021.

    Hibbett Sports Inc. (HIBB), a Specialty Retail company, rose about 6.81% at $45.0 in pre-market trading Friday after firm earnings results topped estimates.

    Amarin Corporation plc (AMRN) stock moved up 16.74 percent to $5.3 in the pre-market trading as the company shared topline data from the pivotal phase 3 study of VASCEPA® in mainland China.

    Ocugen Inc. (OCGN) gained over 6.48% at $0.34 in pre-market trading Friday 20 November 2020 as the company revealed a business update with Q3 results.

    Vaxart Inc. (VXRT) is up more than 0.51% at $5.94 in pre-market hours Friday 20 November 2020 after the company announced hosting a key opinion leader panel call for investors. The stock had jumped over 3.68% to $5.91 in the last trading session.

    Before the trading started on 20 November 2020, Spectrum Pharmaceuticals Inc. (SPPI) is down -2.12% to reach $4.15. It has been trading in a 52-week range of $1.74 to $10.57.

    Workday Inc. (WDAY) stock plunged -2.9% to $224.11 in the pre-market trading after the company announced fiscal 2021 third-quarter financial results. The most recent rating by Piper Sandler, on October 20, 2020, is at an Overweight.

    NovaBay Pharmaceuticals Inc. (AMEX: NBY) shares are trading up 16.24% at $0.68 at the time of writing as the company published its Q3 earnings report. The company’s 52-week range was noted as $0.24 to $1.94. Analysts have a consensus price target of $1.10.

    Seelos Therapeutics Inc. (SEEL) tumbled over -6.84% at $0.7521 in pre-market trading today after the company received US orphan drug designation for SLS-005 in Amyotrophic Lateral Sclerosis.

    Catalyst Pharmaceuticals Inc. (CPRX), a Biotechnology company, dropped about -2.71% at $3.23 in pre-market trading Friday after analysts changed forecast following an earnings beat.

    360 DigiTech Inc. (QFIN) stock moved up 9.21 percent to $13.52 in the pre-market trading as the company revealed third quarter 2020 Unaudited financial results.

    Lyft Inc. (LYFT) lost over -2.77% at $39.0 in pre-market trading Friday 20 November 2020 following a report that Motional got approval to test fully driverless vehicles in Nevada.

    Corbus Pharmaceuticals Holdings Inc. (CRBP) is down more than -2.48% at $1.18 in pre-market hours Friday 20 November 2020. The stock had jumped over 0.83% to $1.21 in the last trading session.

    Before the trading started on 20 November 2020, BOQI International Medical Inc. (BIMI) is down -2.2% to reach $1.78. It has been trading in a 52-week range of $1.50 to $7.40 following the announcement of its quarterly results.

    FireEye Inc. (FEYE) stock soared 13.97% to $16.23 in pre-market trading. The most recent rating by BMO Capital Markets, on July 29, 2020, is at a Market performance after the firm revealed the acquisition of respond software.

    Akerna Corp. (NASDAQ: KERN) shares are trading down -2.91% at $2.67 at the time of writing after the report that cannabis sales expected to reach approximately $270M over thanksgiving weekend. The company’s 52-week range was noted as $2.17 to $13.50. Analysts have a consensus price target of $18.